A gemcitabine intermediate compound
Patent Information
- Application Number
- CN202110701151.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-06-22
- Publication Date
- 2026-08-28
- Estimated Expiration
- 2041-06-22
AI Technical Summary
[0021]上述文献中,3-氰基4-甲氧基-2(1H)-吡啶酮的制备方法除文献二氢嘧啶脱氢酶抑制剂吉美拉西的合成.《华西药学杂志》,2008,23(3),252-254中将2-(1-甲氧基亚乙基)丙二腈单独分离制备外,其它文献均以丙二腈为起始物料,“一锅法”制得1,1-二氰基-2-甲氧基-4-(N,N-二甲基氨基)-1,3-丁二烯后再环化制备,但由于环化过程会生成胺臭味的沸点仅为9℃的二甲胺有毒气体,对环境危害较大;并且相关二甲胺气体进一步会与所用溶剂醋酸成盐析出,使得相关产品纯度较低,需要进一步水洗打浆除盐提纯,操作较为繁琐
[0039]1.提供了一种新的吉美嘧啶中间体化合物,同时提供了利用该该新中间体简便高效的制备吉美嘧啶关键中间体3-氰基-4-甲氧基-2(1H)-吡啶酮的方法,整个合成方法操作简便,反应收率高;
Smart Images

Figure QLYQS_1 
Figure QLYQS_2 
Figure BDA0003127168900000011
Abstract
Claims
1. A process for the preparation of a gemiglimine intermediate compound, characterized by, The preparation method includes the following steps: at room temperature, 12.21g of 2-(1-methoxyethylidene)malononitrile and 17.78g of triethyl orthoformate are added to 80mL of 1,4-dioxane and the reaction is carried out at 80-85℃. After the reaction is detected to be complete, the reaction solution is concentrated to dryness under reduced pressure to obtain I-1. At room temperature, 8.91 g of intermediate I-1 was added to 60 mL of 80% acetic acid solution, and the reaction was carried out under controlled reflux. After the reaction was completed, the reaction solution was cooled to 25°C to induce crystallization, and light yellow needle-like crystals precipitated out. The crystals were filtered, and the resulting filter cake was washed with water and dried to obtain the target product I. The synthesis route is as follows: ; 。
Citation Information
Patent Citations
Process for production of 5-chloro-2,4-dihydroxypyridine
CN101107230A
Synthetic method for gimeracil
CN106316934A
Preparation method of gimeracil intermediate
CN112110854A
Process for production of 5-chloro-2,4-dihydroxypyridine
EP1842847A1
Alpha,beta-unsaturated ketoester derivative
JP1993039241A